Search Results 231-240 of 18875 for Neutrophil

1. SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence - Mayo Clinic

   Absolute neutrophil count < 500 cells/mm3. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most up-to ...

2. Hodgkin lymphoma (Hodgkin disease) - Diagnosis and treatment - Mayo Clinic

   In febrile neutropenia, the body is trying to fight an infection but doesn't have enough neutrophils. Medicine toxicity. Some medicines used to treat cancer can ...

3. Clinical trials - Oncology (Medical)

   MC1733, Phase I Trial of Intratumoral Administration of a Measles Virus Derivative Expressing the Helicobacter pylori Neutrophil-activating Protein (NAP) ...

4. Dermatology - Doctors - Mayo Clinic

   Afsaneh Alavi, M.D.. Dermatologist. Rochester, MN. Areas of focus: Psoriasis, Hidradenitis suppurativa, Pyoderma gangrenosum, Neutrophilic dermatoses, Drug ...

5. Clinical trials - Oncology (Medical)

   MC1733, Phase I Trial of Intratumoral Administration of a Measles Virus Derivative Expressing the Helicobacter pylori Neutrophil-activating Protein (NAP) ...

6. Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer - Mayo Clinic

   Absolute neutrophil count (ANC) ≥1500/mm3;; Platelet count 100,000/mm3;; Hemoglobin ≥9.0 g/dL;; Total bilirubin ULN;; NOTE: If total bilirubin is out of range ...

7. A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies

   Absolute neutrophil count ≥ 1500/mm3; Platelet count ≥ 75,000/mm3. Arms B, C, and D must meet the following criteria: Hemoglobin ≥ 8 g/dL; Absolute ...

8. Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET) - Mayo Clinic

   Neutrophil count <1.5 x 10 to 9/L; JAK2 exon 12 mutation: PV that lacks the JAK2V617F mutation but is characterized by the exon 12 mutation. Patients cannot ...

9. Clinical trials - Oncology (Medical)

   MC1733, Phase I Trial of Intratumoral Administration of a Measles Virus Derivative Expressing the Helicobacter pylori Neutrophil-activating Protein (NAP) ...

10. Rituximab Vasculitis Maintenance Study - Clinical Trials

    Rituximab is now established as an effective drug for anti-neutrophil cytoplasmic antibody (ANCA) vasculitis following major European and US trials reported in ...